Ackerstein Group Ltd.

Major Shareholding Notification • Oct 15, 2025

ACKERSTEIN GROUP LTD

ACKERSTEIN GROUP LTD

Registration Number: 512714494

To: Israel Securities Authority To: Tel Aviv Stock Exchange Ltd.

Form T077 (Public)

Transmitted via MAGNA: 15/10/2025

Israel Securities Authority: www.isa.gov.il Tel Aviv Stock Exchange: www.tase.co.il

Reference: 2025-01-075289

Immediate Report on the Holdings of Interested Parties and Senior Officers

Regulation 33 (c)-(d) of the Securities Regulations (Periodic and Immediate Reports), 1970
Reference numbers of previous reports on the subject: , ,
Below is the status as of 30/09/2025:

A. Interested Parties in the Corporation (including CEO and directors, and any other employee holding five percent or more of the issued share capital or voting power):

Holder Number	Holder Name	Name, Type, and Series of Security	Updated Quantity of Securities	Holding Percentage	Holding Percentage (Fully Diluted)
1	Giora Ackerstein	Ordinary Share	39,618,696	13.73% equity, 13.73% voting	13.55% equity, 13.55% voting
2	Stephanie (Shula) Ackerstein	Ordinary Share	38,691,696	13.41% equity, 13.41% voting	13.23% equity, 13.23% voting
3	Karin Klier Ackerstein	Ordinary Share	38,691,696	13.41% equity, 13.41% voting	13.23% equity, 13.23% voting
4	Maya Lippin Ackerstein	Ordinary Share	38,691,696	13.41% equity, 13.41% voting	13.23% equity, 13.23% voting
5	Zvi Ben Ackerstein	Ordinary Share	38,858,696	13.47% equity, 13.47% voting	13.29% equity, 13.29% voting
6	CLAL INSURANCE ENTERPRISES HOLDINGS LTD.	Ordinary Share	21,732,555	7.53% equity, 7.53% voting	7.43% equity, 7.43% voting
7	MEITAV INVESTMENT HOUSE LTD - Companies Managing Mutual Fund Investments	Ordinary Share	1,424,640	0.49% equity, 0.49% voting	0.49% equity, 0.49% voting

Holder Number	Holder Name	Name, Type, and Series of Security	Updated Quantity of Securities	Holding Percentage	Holding Percentage (Fully Diluted)
8	MEITAV INVESTMENT HOUSE LTD - Provident Funds and Companies Managing Provident Funds	Ordinary Share	15,605,105	5.41% equity, 5.41% voting	5.34% equity, 5.34% voting
9	MEITAV MARKET MAKING LTD	Ordinary Share	-1,661	0% equity, 0% voting	0% equity, 0% voting

Total Holding Percentage:

80.86% equity, 80.86% voting

Total Holding Percentage (Fully Diluted):

79.79% equity, 79.79% voting

B. Senior Officers in the Corporation (excluding CEO and directors, and any other employee holding five percent or more of the issued share capital or voting power):

• Do not hold securities of the corporation.
• Below is the status of holdings of senior officers in the corporation:

Holder Number	Holder Name	Name, Type, and Series of Security	Updated Quantity of Securities	Holding Percentage	Holding Percentage (Fully Diluted)
10	Eyal Weinberg	Ordinary Share	1,480,801	0% equity, 0% voting	0.5% equity, 0.5% voting

Total Holding Percentage: 0% equity, 0% voting

Total Holding Percentage (Fully Diluted): 0.5% equity, 0.5% voting

Explanations:

• 1. It is required to report also on the holding of other securities, including those not listed for trading.
• 1. If the interested party holds more than one type of security in the corporation, the holding percentage (including fully diluted) should be stated considering all securities held by him in a single row.
• 1. This form should detail the holdings of all interested parties, including those whose holdings have not changed.
• 1. If the interested party is a held company with significant activity for the corporation, the holdings should be split between shares acquired before the Companies Law, 1999 came into effect (granting rights in capital and voting) and shares acquired after (which are dormant shares).
• 1. If the interested party is a corporation, also state the first name(s) of the ultimate controlling shareholder(s) in this corporation. If there is no controlling shareholder, provide details of the interested parties in it.
• 1. If a senior officer holds five percent or more of the issued share capital or voting power, his holdings should be detailed in the "Interested Parties" table as detailed in section A above.
• 1. If the interested party or senior officer also holds securities in a held company whose activities are significant for the corporation, details of these holdings should be provided in the "Remarks" field in the holder's details.

Details of the Controlling Shareholders in the Corporation

As of the date of this report and according to the law, is there a controlling shareholder in the corporation?

Yes
No
Other:

The controlling shareholders in the corporation are:

No.	Name	ID Type	ID Number	Was control transferred during the period described in the report?
1	Giora Ackerstein	ID Card Number	7730849	No
2	Stephanie (Shula) Ackerstein	ID Card Number	44529816	No
3	Karin Klier Ackerstein	ID Card Number	023077985	No
4	Maya Lippin Ackerstein	ID Card Number	024963035	No
5	Zvi Ben Ackerstein	ID Card Number	032254021	No

Total holding percentage (%) in the corporation's capital by all controlling shareholders: 67.44%

Details of the Authorized Signatories on Behalf of the Corporation

No.	Name	Position
1	Saar Egozi	Legal Advisor

Explanation: According to Regulation 5 of the Periodic and Immediate Reports Regulations (1970), a report submitted under these regulations must be signed by those authorized to sign on behalf of the corporation. The staff's position on the matter can be found on the Authority's website: Click here.

Additional Information

• The corporation's securities are listed for trading on the Tel Aviv Stock Exchange.
• Short name: ACKERSTEIN GROUP LTD
• Address: Medinat HaYehudim 103, Herzliya 4676679
• Phone: 09-9596622, Fax: 09-9543130
• Email: saare@ackerstein.co.il
• Company website: http://www.ackerstein.co.il/profile

Electronic Signatory Name: Saar Egozi

Position: Legal Advisor and Company Secretary

Address: Medinat HaYehudim 103, Herzliya 4676679

Phone: 09-9596622 Fax: 09-6556770

Email: SaarE@ackerstein.co.il

Previous names of the reporting entity:

Explanatory notes and remarks are included in the relevant sections above.

No images were present in the original document.